Veterinary Molecular Diagnostics Market Size & Growth Forecast 2027–2036, By Segments (End-use, Product, Technology, Application, Animal Type), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Veterinary Molecular Diagnostics Market size was worth USD 1.5 billion in 2026 and is poised to grow at a 9.98% CAGR between 2027 and 2036, attaining USD 3.88 billion by 2036. The industry revenue for 2027 is assessed at USD 1.63 billion.
Get more details on this report
Request Free Sample ReportVeterinary Molecular Diagnostics Market Intelligence Snapshot
Regional Market Dynamics
- North America leads with a 40.92% share due to advanced animal healthcare infrastructure, high testing volumes, and routine integration of molecular diagnostics for rapid disease detection.
- Asia Pacific’s 11.76% CAGR is driven by rising animal health awareness, improved veterinary access, expanding livestock systems, and growing adoption of modern molecular diagnostics.
Segment Momentum
- Test Kits & Reagents held a 49.82% market share in 2026 because every molecular testing workflow requires recurring consumables, making continuous replenishment essential for routine diagnostic operations across laboratories and veterinary care settings.
- Instruments are expanding fastest as providers invest in greater testing capacity, workflow automation, and modern diagnostic infrastructure to support broader adoption of in-house and laboratory-based molecular testing.
Market Expansion Drivers
- Rising prevalence of zoonotic diseases increasing demand for rapid veterinary molecular testing solutions.
- Advancements in PCR and next-generation sequencing improving veterinary diagnostic accuracy and speed.
- Expansion of proactive pet healthcare and DNA testing services driving companion animal diagnostics adoption.
Leading Market Participants
- Prominent companies in the veterinary molecular diagnostics market include IDEXX Laboratories, Inc. (United States), Zoetis Inc. (United States), Thermo Fisher Scientific Inc. (United States), QIAGEN N.V. (Netherlands), Bio-Rad Laboratories, Inc. (United States), Neogen Corporation (United States), Antech Diagnostics, Inc. (United States), bioMérieux SA (France), Eurofins Scientific SE (Luxembourg), Bionote Co., Ltd. (South Korea).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 1.5 billion
- 2027 Estimated Market Size: USD 1.63 billion.
- Projected Market Size: USD 3.88 billion by 2036
- Growth Forecast: 9.98% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Veterinary Hospitals & Clinics (End-use) | Test Kits & Reagents (Product) | PCR (Technology) | Infectious Diseases (Application) | Companion Animal (Animal Type)
- Emerging Opportunity Segment: Veterinary Hospitals & Clinics (End-use) | Instruments (Product) | DNA Sequencing (Technology) | Genetics (Application) | Companion Animal (Animal Type)
Market Growth Drivers and Industry Trends
Rising prevalence of zoonotic diseases increasing demand for rapid veterinary molecular testing solutions
The increasing occurrence and surveillance of diseases capable of transmitting between animals and humans are strengthening the need for rapid and reliable animal testing, which will drive the veterinary molecular diagnostics market. Molecular diagnostic methods can identify pathogens with high specificity and support earlier detection compared with approaches that rely solely on clinical symptoms or conventional laboratory techniques. Rapid identification is particularly important for veterinary practices, livestock operations, and animal health authorities seeking to control disease transmission and protect animal populations. Increased attention to animal-to-human disease pathways is also encouraging broader diagnostic monitoring across both companion and production animals.
Advancements in PCR and next-generation sequencing improving veterinary diagnostic accuracy and speed
Technological progress in molecular testing is expanding the capabilities of veterinary laboratories and clinics, thereby propelling the veterinary molecular diagnostics market through faster and more comprehensive disease detection. PCR technologies can provide sensitive identification of specific pathogens, while next-generation sequencing enables broader analysis of genetic material and supports the investigation of complex infections. Improvements in assay design, automation, sample processing, and data interpretation are making advanced molecular methods increasingly practical for veterinary applications. These capabilities can help clinicians distinguish between closely related pathogens and support more informed treatment, surveillance, and disease-control decisions.
Expansion of proactive pet healthcare and DNA testing services driving companion animal diagnostics adoption
Pet owners are becoming more proactive about preventive healthcare, creating additional demand for diagnostic services that support early disease detection and personalized animal care. This shift will boost the veterinary molecular diagnostics market as companion animal testing expands beyond diagnosis of active illness to include genetic screening, inherited disease assessment, breed-related health evaluation, and other DNA-based services. Molecular testing can provide veterinarians with detailed information that supports preventive care planning and helps owners understand potential health risks in their animals. Growing willingness to invest in advanced pet healthcare is also encouraging veterinary practices to incorporate specialized diagnostic services into routine companion animal management.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising prevalence of zoonotic diseases increasing demand for rapid veterinary molecular testing solutions | 2.00% | High | North America, Asia Pacific | High | Near Term |
| Advancements in PCR and next-generation sequencing improving veterinary diagnostic accuracy and speed | 1.80% | Moderate | Europe, Asia Pacific | High | Mid Term |
| Expansion of proactive pet healthcare and DNA testing services driving companion animal diagnostics adoption | 1.50% | Moderate | North America, Europe | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the veterinary molecular diagnostics market with a 40.92% share in 2026, supported by advanced veterinary healthcare infrastructure, high awareness of animal diseases, and widespread adoption of laboratory-based diagnostic technologies. The region has a well-developed companion animal healthcare ecosystem alongside substantial demand for livestock disease management, creating diverse applications for molecular testing. Growing emphasis on early and accurate disease identification is encouraging veterinarians and animal health providers to adopt diagnostic methods capable of detecting pathogens and genetic markers with greater precision. Strong veterinary care standards, sophisticated laboratory capabilities, and increasing attention to animal health and preventive care further contribute to the region’s established market position.
Asia Pacific (Fastest-Growing Region)
Asia Pacific is anticipated to be the fastest-growing region in the veterinary molecular diagnostics market, supported by expanding veterinary healthcare infrastructure, rising livestock production, and increasing awareness of animal disease prevention. Growing demand for efficient disease surveillance is encouraging the adoption of molecular diagnostic techniques across livestock, poultry, and companion animal applications. The expansion of commercial farming and improvements in animal healthcare services are also increasing the need for rapid and reliable diagnostic solutions to support herd health and reduce disease-related losses. At the same time, rising pet ownership in several countries is broadening demand for advanced companion animal diagnostics, while investments in veterinary laboratories and healthcare capabilities are helping accelerate the adoption of molecular testing technologies.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants/Startups i Scale Low Medium High | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Laboratory Quality EnhancementGermany focuses on veterinary molecular diagnostics that deliver standardized testing performance and reliable laboratory workflows. Veterinary institutions in Germany increasingly adopt molecular platforms capable of improving diagnostic accuracy while supporting disease monitoring programs.
France 🇫🇷
Livestock Disease SurveillanceFrance places strong emphasis on veterinary molecular diagnostics that support livestock health management alongside companion animal care. Diagnostic adoption in France is driven by the need for reliable testing methods that enhance disease control and veterinary decision-making.
Italy 🇮🇹
Veterinary Practice ModernizationItaly is incorporating veterinary molecular diagnostics into routine clinical practice as veterinary services seek faster and more accurate testing capabilities. Veterinary professionals in Italy increasingly value molecular platforms that improve diagnostic confidence across diverse animal health applications.
Japan 🇯🇵
Preventive Animal HealthJapan is expanding veterinary molecular diagnostics as preventive healthcare gains greater importance for companion animals and commercial livestock. Diagnostic providers in Japan emphasize highly sensitive testing solutions that enable earlier disease identification and efficient veterinary management.
South Korea 🇰🇷
Biosecurity Testing ExpansionSouth Korea continues to strengthen veterinary molecular diagnostics to support animal disease surveillance and biosecurity initiatives. Veterinary laboratories in South Korea prioritize rapid molecular testing technologies that improve outbreak detection and routine health monitoring.
United States 🇺🇸
Companion Animal Testing FocusThe U.S. continues to strengthen veterinary molecular diagnostics through increasing demand for rapid and accurate disease detection in companion animals and livestock. Veterinary laboratories across the U.S. prioritize platforms that support timely diagnosis, surveillance, and treatment decision-making.
Segment Leadership and Growth Trends
Veterinary Molecular Diagnostics Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Veterinary Hospitals & Clinics (Largest & Fastest-Growing Segment)
Veterinary hospitals & clinics represented the largest and fastest-growing end-use segment in the veterinary molecular diagnostics market, holding a 54.5% share in 2026. These facilities serve as primary points for diagnostic evaluation, disease screening, treatment planning, and follow-up care, creating sustained demand for molecular testing. Greater awareness of infectious and genetic diseases, along with increasing use of rapid and precise diagnostic methods, is encouraging veterinary professionals to integrate molecular diagnostics more deeply into routine clinical workflows.
Product Segment Analysis: Test Kits & Reagents (Largest Segment) vs Instruments (Fastest-Growing Segment)
Test kits & reagents accounted for the largest share of 49.82% in 2026, reflecting their recurring role in veterinary molecular testing. These products are essential for sample preparation, pathogen identification, genetic analysis, and diagnostic workflows, resulting in continued consumption across veterinary laboratories and clinical settings. Expanding diagnostic screening and the increasing need for reliable disease identification support sustained demand for ready-to-use testing materials.
Instruments are gaining traction as veterinary laboratories and clinics adopt more sophisticated molecular diagnostic capabilities. Advances in automated testing, improved analytical precision, and faster processing are encouraging investment in equipment that can support broader testing workloads. The growing integration of molecular diagnostics into veterinary practice is also increasing the need for dedicated platforms capable of delivering consistent and efficient results.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Veterinary Hospitals & Clinics, Diagnostic Laboratories, Others | Veterinary Hospitals & Clinics | Veterinary Hospitals & Clinics |
| Product | Instruments, Test Kits & Reagents, Software & Services | Test Kits & Reagents | Instruments |
| Technology | PCR, DNA Sequencing, Microarrays, INAAT Kits | PCR | DNA Sequencing |
| Application | Infectious Diseases, Metabolic Disease, Genetics, Others | Infectious Diseases | Genetics |
| Animal Type | Companion Animal, Production Animals | Companion Animal | Companion Animal |
Competitive Landscape and Market Positioning
Prominent players in the veterinary molecular diagnostics market:
1. IDEXX Laboratories Inc. (United States)
2. Zoetis Inc. (United States)
3. Thermo Fisher Scientific Inc. (United States)
4. QIAGEN N.V. (Netherlands)
5. Bio-Rad Laboratories Inc. (United States)
6. Neogen Corporation (United States)
7. Antech Diagnostics Inc. (United States)
8. bioMérieux SA (France)
9. Eurofins Scientific SE (Luxembourg)
10. Bionote Co. Ltd. (South Korea)
The veterinary molecular diagnostics market is evolving through enhanced adoption of advanced genetic and molecular testing techniques for animal health management. Improved diagnostic accuracy is supporting earlier disease detection and better treatment planning. The veterinary molecular diagnostics market is also expanding as veterinary care becomes more preventive and data-driven in approach.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| IDEXX Laboratories Inc. (United States) | |||||||
| Zoetis Inc. (United States) | |||||||
| Thermo Fisher Scientific Inc. (United States) | |||||||
| QIAGEN N.V. (Netherlands) | |||||||
| Bio-Rad Laboratories Inc. (United States) | |||||||
| Neogen Corporation (United States) | |||||||
| Antech Diagnostics Inc. (United States) | |||||||
| bioMérieux SA (France) | |||||||
| Eurofins Scientific SE (Luxembourg) | |||||||
| Bionote Co. Ltd. (South Korea). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| Digital Landia | May-25 | Digital Landia launched Agentic.Pet, an artificial intelligence platform designed to aggregate and interpret complex veterinary diagnostic data, including blood, urine, and radiology results. By providing automated clinical insights, the platform supports veterinarians in streamlining decision-making and improving diagnostic accuracy for companion animal health management. |
| Alveo Technologies | Feb-25 | Alveo Technologies and Royal GD formed a multiyear commercial alliance to deploy the Sense Poultry Avian Influenza test. The diagnostic tool delivers results in under 45 minutes and features real-time cloud reporting, enhancing surveillance and response capabilities for poultry health management in agricultural and industrial settings. |
| bioMérieux | Jan-25 | bioMérieux finalized the acquisition of SpinChip Diagnostics, a strategic move to integrate high-sensitivity, point-of-care whole-blood diagnostic technology into its portfolio. This acquisition enables rapid, 10-minute diagnostic turnaround times, strengthening the company’s ability to provide efficient, near-patient molecular testing solutions for veterinary and human clinical environments. |
| IDEXX Laboratories | Jan-25 | IDEXX Laboratories launched the IDEXX Cancer Dx, a specialized molecular diagnostic panel for the early detection of canine lymphoma. The company intends to scale this panel over the next three years to address a broad spectrum of canine cancers, reinforcing its dominant position in the veterinary oncology diagnostics sector. |
| Mars | Jul-24 | Mars acquired Cerba HealthCare’s stakes in Cerba Vet and ANTAGENE. This significant investment expands Mars’ global veterinary reference-laboratory network, enhancing its service infrastructure and molecular diagnostic capabilities across Europe to support comprehensive pet health and genetics testing. |
| MiDOG Animal Diagnostics | Feb-24 | MiDOG Animal Diagnostics introduced an All-in-One Diagnostic Test utilizing advanced molecular detection to identify bacterial and fungal infections, including antibiotic resistance profiles. The platform replaces traditional culture methods with molecular sequencing, allowing for more precise treatment strategies across a diverse range of animal species, from common pets to exotics. |
| Royal GD | Jan-24 | Royal GD and PathoSense entered into an exclusive distribution partnership for the Dutch market. PathoSense’s diagnostic assay utilizes nanopore sequencing to provide comprehensive, unbiased pathogen detection in animal samples, allowing for rapid identification of complex viral and bacterial infections without the need for prior target selection. |
| Alveo Technologies | Jul-23 | Alveo Technologies collaborated with Germany’s Fraunhofer Institute for Cell Therapy and Immunology (IZI) to co-develop molecular diagnostic tests using the be.well handheld LAMP platform. This initiative focuses on streamlining veterinary testing by bringing rapid, laboratory-grade molecular diagnostics closer to the point of care for improved clinical efficiency. |
| Neogen Corporation | Jun-23 | Neogen Corporation launched My CatScan 2.0, an upgraded genetic screening platform for feline health. By enhancing its molecular testing technology, Neogen strengthened its diagnostic product portfolio, providing veterinarians and pet owners with more accurate insights for hereditary disease management and preventive healthcare. |
| INDICAL BIOSCIENCE | Nov-22 | INDICAL BIOSCIENCE launched its updated virotype 2.0 PCR kit range, which features a harmonized and streamlined reaction setup. By unifying cycling protocols across all assays, the platform improves laboratory operational efficiency and reduces training time, setting a higher standard for throughput and consistency in veterinary molecular diagnostic workflows. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Veterinary Molecular Diagnostics Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Sample Type | Blood, Fecal Samples, Swabs & Secretions, Urine, Tissue Samples |
| Test Format | Single-Target Tests, Multiplex Tests, Syndromic Panels, Comprehensive Panels |
| Automation Level | Manual, Semi-Automated, Fully Automated |
Veterinary Molecular Diagnostics Market — Custom
| Custom Chapter | Custom Details |
|---|---|
| Companion and Livestock Diagnostics Opportunity Assessment |
|
| Animal Disease Surveillance and Testing Demand Outlook |
|
| Point-of-Care Veterinary Diagnostics Adoption Analysis |
|
Need a different cut of the data?
Request Custom ResearchWhat is the market size of veterinary molecular diagnostics?
How is the veterinary molecular diagnostics industry projected to perform over the next decade?
How is rising zoonotic disease risk reshaping purchasing priorities in the veterinary molecular diagnostics market?
What impact are PCR and next-generation sequencing advancements having on diagnostic adoption and workflow efficiency?
Why are Test Kits & Reagents the leading product segment in the veterinary molecular diagnostics market?
Why are Instruments the fastest-growing product segment in the veterinary molecular diagnostics market?
Why does North America lead the veterinary molecular diagnostics market?
What drives Asia Pacific’s fastest growth in the veterinary molecular diagnostics market?
Which organizations are considered leaders in the veterinary molecular diagnostics landscape?
Our Clients
"The reports offered a comprehensive view of the Food and Beverage landscape, covering market trends, consumer behavior, and competitive dynamics."
"Our experience in acquiring market research reports has been outstanding — the depth of analysis and actionable insights have proven invaluable."
"Fundamental Business Insights demonstrated a keen understanding of our business needs, delivering reports tailored to our specific objectives."
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Why It Matters | Reference |
|---|---|---|
| World Health Organization (WHO) | Global health statistics, disease burden, healthcare policies | www.who.int |
| U.S. Food & Drug Administration (FDA) | Medical devices, pharmaceuticals, diagnostics, approvals | www.fda.gov |
| European Medicines Agency (EMA) | Pharmaceutical approvals and regulatory guidance in Europe | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | Disease surveillance, public health, epidemiology | www.cdc.gov |
| National Institutes of Health (NIH) | Biomedical research, clinical studies, funding | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | Biomedical databases, PubMed, genomics | www.ncbi.nlm.nih.gov |
| PubMed | Peer-reviewed biomedical literature | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | Global clinical trial registry | clinicaltrials.gov |
| International Organization for Standardization (ISO) | Medical device quality and healthcare standards | www.iso.org |
| ASTM International | Medical device testing and material standards | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | Medical devices and diagnostics industry | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | Medical device innovation and regulatory science | mdic.org |
| Biotechnology Innovation Organization (BIO) | Biotechnology industry developments | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | Global pharmaceutical industry | www.ifpma.org |
| U.S. Pharmacopeia (USP) | Drug quality standards and reference materials | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | European pharmaceutical quality standards | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | Veterinary healthcare and animal diseases | www.woah.org |
| American Hospital Association (AHA) | Hospital operations and healthcare delivery | www.aha.org |
| OECD Health | International healthcare expenditure and system statistics | www.oecd.org/health |
| World Bank Data | Healthcare expenditure and demographic indicators | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization